Showing results (11-20 of 42) with videos related to
Sort By:
Pageof 5
World Journal of Gastroenterology|June 28, 2012
Impact of ribavirin dose on retreatment of chronic hepatitis C patientsChristiane Stern, Michelle Martinot-Peignoux, Marie Pierre Ripault, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 28, 2014
Serum Levels of Hepatitis B Surface Antigen Predict Severity of Fibrosis in Patients With E Antigen-Positive Chronic Hepatitis BPatrick Marcellin, Michelle Martinot-Peignoux, Tarik Asselah, et al.Antimicrobial Agents and Chemotherapy|November 19, 2014
Impact of treatment against hepatitis C virus on overall survival of naive patients with advanced liver diseaseBlaise K Kutala, Jeremie Guedj, Tarik Asselah, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 22, 2011
Role of hepatic HCV-RNA level on the severity of chronic hepatitis C and response to antiviral therapySarah Maylin, Cédric Laouénan, Michelle Martinot-Peignoux, et al.Journal of Hepatology|April 12, 2002
Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriersMichelle Martinot-Peignoux, Nathalie Boyer, Magalie Colombat, et al.Hepatology (Baltimore, Md.)|August 30, 2008
Significant gene expression differences in histologically "Normal" liver biopsies: Implications for control tissueTarik Asselah, Ivan Bièche, Ingrid Laurendeau, et al.Plos One|April 7, 2015
IFI35, mir-99a and HCV genotype to predict sustained virological response to pegylated-interferon plus ribavirin in chronic hepatitis CEmilie Estrabaud, Kevin Appourchaux, Ivan Bièche, et al.Journal of Hepatology|February 2, 2013
Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patientsMichelle Martinot-Peignoux, Roberto Carvalho-Filho, Martine Lapalus, et al.Antiviral Therapy|January 24, 2012
Quasispecies analysis and in vitro susceptibility of HBV strains isolated from HIV-HBV-coinfected patients with delayed response to tenofovirOlivier Lada, Anne Gervais, Michel Branger, et al.Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2011
Long-term outcome of primary non-responders to tenofovir therapy in HIV/HBV-co-infected patients: impact of HBV genotype GOlivier Lada, Anne Gervais, Michel Branger, et al.Pageof 5